Lipopolysaccharide-induced cellular activation may participate in the immunopathogenesis of visceral leishmaniasis alone or in HIV coinfection

International Journal of Microbiology

Volumn , Issue , 2012, Pages

  Santos Oliveira, Joanna Reis ^a   Da Cruz, Alda Maria ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84866235204     PISSN: 1687918X     EISSN: 16879198     Source Type: Journal    
DOI: 10.1155/2012/364534     Document Type: Review

References (33)

1. Alvar J., Vélez I., Bern C., Leishmaniasis worldwide and global estimates of this prevalence. Plos One 2012 7 5 e35671
2. Maia-Elkhoury A. N. S., Carmo E. H., Sousa-Gomes M. L., Mota E., Analysis of visceral leishmaniasis reports by the capture-recapture method. Revista de Saúde Pública 2007 41 6 931 937 2-s2.0-38049181381
3. Kuhls K., Alam M. Z., Cupolillo E., Ferreira G. E. M., Mauricio I. L., Oddone R., Feliciangeli M. D., Wirth T., Miles M. A., Schönian G., Comparative microsatellite typing of new world Leishmania infantum reveals low heterogeneity among populations and its recent old world origin. PLoS Neglected Tropical Diseases 2011 5 6 2-s2.0-79959861777 10.1371/journal.pntd.0001155 e1155
4. Saha S., Mondal S., Banerjee A., Ghose J., Bhowmick S., Ali N., Immune responses in kala-azar. Indian Journal of Medical Research 2006 123 3 245 266 2-s2.0-33745187998 (Pubitemid 43905567)
5. Costa C. H. N., Werneck G. L., Costa D. L., Holanda T. A., Aguiar G. B., Carvalho A. S., Cavalcanti J. C., Santos L. S., Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Revista da Sociedade Brasileira de Medicina Tropical 2010 43 4 386 392 2-s2.0-77957979610
6. Alvar J., Aparicio P., Aseffa A., Den Boer M., Cañavate C., Dedet J. P., Gradoni L., Ter Horst R., López-Vélez R., Moreno J., The relationship between leishmaniasis and AIDS: the second 10 years. Clinical Microbiology Reviews 2008 21 2 334 359 2-s2.0-42349108596 10.1128/CMR.00061-07 (Pubitemid 351555511)
7. Carvalho E. M., Teixeira R. S., Johnson W. D., Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection. Infection and Immunity 1981 33 2 498 502 2-s2.0-0019442454 (Pubitemid 11042661)
8. Karp C. L., El-Safi S. H., Wynn T. A., Satti M. M. H., Kordofani A. M., Hashim F. A., Hag-Ali M., Neva F. A., Nutman T. B., Sacks D. L., In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. Journal of Clinical Investigation 1993 91 4 1644 1648 2-s2.0-0027159096 (Pubitemid 23127368)
9. + monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection. Clinical and Experimental Immunology 2006 146 1 124 132 2-s2.0-33748682825 10.1111/j.1365-2249.2006.03171. x (Pubitemid 44393847)
10. Santos-Oliveira J. R., Regis E. G., Leal C. R. B., Cunha R. V., Bozza P. T., Da-Cruz A. M., Evidence that lipopolysaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis. PLoS Neglected Tropical Diseases 2011 5 7 2-s2.0-79960959727 10.1371/journal.pntd.0001198 e1198
11. Singh O. P., Gidwani K., Kumar R., Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clinical Vaccine Immunology 2012 19 6 961 966
12. Carvalho E. M., Bacellar O., Barral A., Badaro R., Johnson W. D., Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. Journal of Clinical Investigation 1989 83 3 860 864 2-s2.0-0024516729 (Pubitemid 19080617)
13. Carvalho E. M., Bacellar O., Brownell C., Regis T., Coffman R. L., Reed S. G., Restoration of IFN- γ production and lymphocyte proliferation in visceral leishmaniasis. Journal of Immunology 1994 152 12 5949 5956 2-s2.0-0028181286
14. Caldas A., Favali C., Aquino D., Vinhas V., van Weyenbergh J., Brodskyn C., Costa J., Barral-Netto M., Barral A., Balance of IL-10 and interferon- γ plasma levels in human visceral leishmaniasis: implications in the pathogenesis. BMC Infectious Diseases 2005 5 113 121 2-s2.0-29944437637 10.1186/1471-2334-5-113 (Pubitemid 43040537)
15. Goto H., Prianti M. D. G., Immunoactivation and immunopathogeny during active visceral leishmaniasis. Revista do Instituto de Medicina Tropical de São Paulo 2009 51 5 241 246 2-s2.0-70449678733 10.1590/S0036- 46652009000500002
16. Barral-Netto M., Barral A., Santos S. B., Carvalho E. M., Badaro R., Rocha H., Reed S. G., Johnson W. D., Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis. Journal of Immunology 1991 147 1 281 284 2-s2.0-0026052485
17. Soares N. M., Ferraz T. P. L., Nascimento E. G., Carvalho E. M., Pontes-de-Carvalho L., The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins. Microbial Pathogenesis 2006 40 6 254 260 2-s2.0-33746833723 10.1016/j.micpath.2006.02.005
18. Barral-Netto M., Badaro R., Barral A., Almeida R. P., Santos S. B., Badaro F., Pedral-Sampaio D., Carvalho E. M., Falcoff E., Falcoff R., Tumor necrosis factor (cachectin) in human visceral leishmaniasis. Journal of Infectious Diseases 1991 163 4 853 857 2-s2.0-0025891596
19. + (Foxp3) regulatory T cells in human visceral leishmaniasis. Journal of Experimental Medicine 2007 204 4 805 817 2-s2.0-34247350697 10.1084/jem.20061141 (Pubitemid 46631610)
20. Douek D. C., Roederer M., Koup R. A., Emerging concepts in the immunopathogenesis of AIDS. Annual Review of Medicine 2009 60 471 484 2-s2.0-63449124466 10.1146/annurev.med.60.041807.123549
21. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. Journal of Experimental Medicine 2004 200 6 749 759 2-s2.0-4644342929 10.1084/jem.20040874 (Pubitemid 39299461)
22. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 2006 12 12 1365 1371 2-s2.0-33845532053 10.1038/nm1511 (Pubitemid 44924494)
23. Brenchley J. M., Douek D. C., Microbial translocation across the GI tract. Annual Reviews of Immunology 2012 30 149 173
24. Harrison O. J., Maloy K. J., Innate immune activation in intestinal homeostasis. Journal of Innate Immunology 2011 3 6 585 593
25. Cooke K. R., Olkiewicz K., Erickson N., Ferrara J. L. M., The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. Journal of Endotoxin Research 2002 8 6 440 448 2-s2.0-0038500966 (Pubitemid 36104598)
26. Baba C. S., Makharia G. K., Mathur P., Ray R., Gupta S. D., Samantaray J. C., Chronic diarrhea and malabsorption caused by Leishmania donovani. Indian Journal of Gastroenterology 2006 25 6 309 310 2-s2.0-33947540960 (Pubitemid 46708830)
27. Luz K. G., Tuon F. F., Duarte M. I. S., Maia G. M., Matos P., Ramos A. M. O., Nicodemo A. C., Cytokine expression in the duodenal mucosa of patients with visceral leishmaniasis. Revista da Sociedade Brasileira de Medicina Tropical 2010 43 4 393 395 2-s2.0-77958001368
28. Sandler N. G., Koh C., Roque A., Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 2010 141 4 1220 1230
29. Müller N., Von Allmen N., Recent insights into the mucosal reactions associated with Giardia lamblia infections. International Journal for Parasitology 2005 35 13 1339 1347 2-s2.0-26944482353 10.1016/j.ijpara.2005.07. 008 (Pubitemid 41484147)
30. Barreto-De-Souza V., Pacheco G. J., Silva A. R., Castro-Faria-Neto H. C., Bozza P. T., Saraiva E. M., Bou-Habib D. C., Increased Leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E 2 synthesis. Journal of Infectious Diseases 2006 194 6 846 854 2-s2.0-33748431196 10.1086/506618 (Pubitemid 44344134)
31. Cota G. F., de Sousa M. R., Rabello A., Predictors of visceral leishmaniasis relapse in hiv-infected patients: a systematic review. PLoS Neglected Tropical Diseases 2011 5 6 2-s2.0-79959822382 10.1371/journal.pntd. 0001153 e1153
32. Santos-Oliveira J. R., Giacoia-Gripp C. B. W., Alexandrino de Oliveira P., Amato V. S., Lindoso J. T. L., Goto H., Oliveira-Neto M. P., Mattos M. S., Grinsztejn B., Morgado M. G., Da-Cruz A. M., High levels of T lymphocyte activation in Leishmania-HIV-1 coinfected individuals despite low HIV viral load. BMC Infectious Diseases 2010 10 358 363 2-s2.0-78650278299 10.1186/1471-2334-10-358
33. Alexandrino-de-Oliveira P., Santos-Oliveira J. R., Dorval M. E. C., da Costa F. C. B., Pereira G. R. O. L., da Cunha R. V., Paniago A. M. M., da-Cruz A. M., HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Memórias do Instituto Oswaldo Cruz 2010 105 5 692 697 2-s2.0-77957238021